Bioorganic and Medicinal Chemistry p. 845 - 854 (2018)
Update date:2022-08-04
Topics:
Liao, Chen
Liu, Yan
Liu, Chunxia
Zhou, Jiaqi
Li, Huilan
Wang, Nasi
Li, Jieming
Liu, Taiyu
Ghaleb, Hesham
Huang, Wenlong
Qian, Hai
Reported herein is the design, synthesis, and pharmacologic characterization of a class of TRPV1 antagonists constructed on a phenylquinoline platform that evolved from Cinchophen lead. This design composes three sections: a phenylquinoline headgroup attached to an aliphatic carboxamides, which is tethered at a phenyl tail group. Optimization of this design led to the identification of 37, comprising a pyrrolidine linker and a trifluoromethyl–phenyl tail. In the TRPV1 functional assay, using cells expressed hTRPV1, 37 antagonized capsaicin-induced Ca2+ influx, with an IC50 value of 10.2 nM. In the complete mice analgesic model, 37 exhibited better antinociceptive activity than the positive control BCTC in diverse pain models. All of these results suggested that 37 could be considered as a lead candidate for the further development of antinociceptive drugs.
View MoreBeijing Zhongshuo Pharmaceutical T & D Co.,Ltd
Contact:0086-10-64430626
Address:ea No 16, HEPINGLI,DONGCHENG DISTRICT,BEIJING,P.R.CHINA.
Contact:+86-25-85281586
Address:13F,Bld2#,South of Longpan Road
Shandong Jiulong Hisince Pharmaceutical Co.,Ltd.
Contact:+86-15853188990
Address:Huadian Pioneer Park, Huadian Township, Qihe County, Dezhou City, Shandong, P.R.China
Engineering Research Center of Pesticide, Heilongjiang Province
Contact:+86-451-86609001
Address:No.74 of Xuefu Road, Nangang District,
SHANGHAI GILEADER ADVANCE MATERIAL TECHNOLOGY CO.,LTD
Contact:+86-021-58692556
Address:No.6 Building,No. 668 Hengan RD Pudong,Shanghai
Doi:10.1016/S0031-9422(00)86891-0
(1994)Doi:10.1248/cpb.39.2271
(1991)Doi:10.1021/jo01352a004
(1957)Doi:10.1021/jo00007a038
(1991)Doi:10.1055/s-0030-1260586
(2011)Doi:10.1016/j.bmcl.2011.06.038
(2011)